Apollo Neuro
Vagal-tone-adjacent haptic wearable for all-day passive use; strongest HRV data in category
WELLNESS
Marketed as a general wellness device. Not FDA cleared, approved, or evaluated for any medical claim.
Key facts at a glance.
- Founded
- 2017
- Headquarters
- Pittsburgh, Pennsylvania, USA
- Trustpilot
- 3.8 / 5 (900)
- App ratings
- iOS 4.6 · Android 4.2
What the device does.
- + Wrist/ankle/clip-on wearable
- + Low-frequency inaudible sound wave vibrations
- + 7 modes (energy, calm, sleep, focus, etc.)
- + iOS/Android app control
- + All-day wear (3+ hours/day recommended)
- + Claimed +11% HRV improvement
- + Apple Health integration
The trade-offs.
- + **Strongest published HRV data in the consumer vagal-tone-adjacent category** — claimed +11% HRV improvement
- + All-day passive wearable form factor (wrist / ankle / clip-on)
- + Apple Health integration for ecosystem fit
- + 7 modes (energy, calm, sleep, focus, etc.) with iOS / Android app
- + 4.6 iOS / 4.2 Android app ratings — highest in VNS category
- − **Not electrical VNS** — vibration-based haptic, mechanism is fundamentally different from cervical or auricular tVNS
- − Requires consistent 3+ hours/day wear for results
- − Mixed efficacy reports among users
- − Band comfort issues documented
- − 3.8 Trustpilot from 900 reviews — mid-tier consumer-experience signal
HRV-tracking biohackers, stressed professionals, sleep-focused users, kids/ADHD
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Apollo Neuro is the vagal-tone-adjacent haptic wearable specialist — manufactured by Apollo Neuroscience (founded 2017 in Pittsburgh), with structural positioning fundamentally different from electrical VNS competitors (gammaCore, Truvaga, Pulsetto, Nurosym): Apollo uses low-frequency inaudible sound wave vibrations delivered through wrist / ankle / clip-on form factor for all-day passive use. Apollo is NOT electrical VNS — it’s a haptic-vibration wearable that influences autonomic state via mechanical stimulation rather than electrical nerve activation.
The structural value claim is genuine within the haptic-wearable niche: claimed +11% HRV improvement is the strongest published HRV data in the consumer vagal-tone-adjacent category. The all-day passive wearable form factor enables ambient autonomic-state intervention without dedicated session commitment. Apple Health integration, 7 modes (energy/calm/sleep/focus/etc.), and 4.6/4.2 app ratings (highest in VNS category) reflect mature consumer-product execution.
The structural editorial caveat is mechanism-positioning: Apollo is haptic, not electrical. Buyers searching for “vagus nerve stimulation” may expect electrical VNS (gammaCore-style cervical, Nurosym-style auricular). Apollo’s vibration-based mechanism influences autonomic state through different pathway. The honest editorial framing: Apollo competes in vagal-tone wellness category but isn’t VNS proper. For users matched to passive haptic-wearable positioning with Apple Health integration, Apollo is appropriate. For users wanting electrical VNS, gammaCore (FDA-cleared) / Truvaga / Pulsetto / Nurosym are structurally appropriate.
When Apollo Neuro Makes Sense
Strong fit: All-day passive autonomic-tone wearable users; Apple Health ecosystem integration; users wanting vibration-based vs electrical mechanism; 7-mode flexibility for varied use cases.
Weaker fit: Electrical VNS preference (gammaCore, Truvaga, Pulsetto, Nurosym); FDA-cleared positioning (gammaCore K211856); users wanting concentrated short sessions vs all-day wear.
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| Apollo Neuro | ~$349 |
| 3-year ownership | ~$349 (no subscription) |
Compare: gammaCore Sapphire ($21,528 / 3 yr cash, FDA-cleared), Truvaga Plus ($799), Pulsetto ($269), Nurosym ($729 + electrodes).
Verdict: Recommended
Apollo Neuro earns a recommended verdict on the strength of its strongest published HRV data in consumer vagal-tone-adjacent category (claimed +11% HRV), all-day passive haptic wearable form factor, Apple Health integration, 7 modes for varied use cases, and 4.6 iOS / 4.2 Android app ratings (highest in VNS category) — with caveat that Apollo is haptic vibration-based, not electrical VNS proper.
For users wanting passive haptic-wearable autonomic-tone intervention with Apple Health ecosystem fit, Apollo Neuro is structurally the leading consumer choice. For users wanting electrical VNS specifically, alternatives are structurally appropriate.
Changelog
- 2026-05-07: Initial review published based on Apollo Neuro published specifications, +11% HRV claim documentation, app-store ratings, Trustpilot review aggregation, and aggregated user-report data.
What we'll measure on the bench.
- Protocol
- Polar H10 + Kubios HRV (pre/post stim)
- Primary metric
- RMSSD delta after 30-min stimulation
- Pass threshold
- ≥+10% RMSSD increase post-stim
- Session shape
- 7 paired pre/post sessions
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.
Common questions.
- Does Apollo Neuro require a subscription?
- No. Apollo Neuro does not require a subscription — there is no mandatory recurring fee to keep using it.
- Is Apollo Neuro FDA cleared?
- No. Apollo Neuro is sold under the FDA's "general wellness" category and is not FDA cleared as a medical device.
- Is Apollo Neuro worth it?
- We rate Apollo Neuro recommended — a strong pick in its category. The review covers who it fits best and its trade-offs.